Cargando…

Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases

A magnetic beads (MB)-involved amperometric immunosensor for the determination of ST2, a member of the IL1 receptor family, is reported in this work. The method utilizes a sandwich immunoassay and disposable screen-printed carbon electrodes (SPCEs). Magnetic immunoconjugates built on the surface of...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrente-Rodríguez, Rebeca M., Martín, Cristina Muñoz-San, Gamella, Maria, Pedrero, María, Martínez-Bosch, Neus, Navarro, Pilar, García de Frutos, Pablo, Pingarrón, José M., Campuzano, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234531/
https://www.ncbi.nlm.nih.gov/pubmed/34205541
http://dx.doi.org/10.3390/bios11060202
_version_ 1783714105363791872
author Torrente-Rodríguez, Rebeca M.
Martín, Cristina Muñoz-San
Gamella, Maria
Pedrero, María
Martínez-Bosch, Neus
Navarro, Pilar
García de Frutos, Pablo
Pingarrón, José M.
Campuzano, Susana
author_facet Torrente-Rodríguez, Rebeca M.
Martín, Cristina Muñoz-San
Gamella, Maria
Pedrero, María
Martínez-Bosch, Neus
Navarro, Pilar
García de Frutos, Pablo
Pingarrón, José M.
Campuzano, Susana
author_sort Torrente-Rodríguez, Rebeca M.
collection PubMed
description A magnetic beads (MB)-involved amperometric immunosensor for the determination of ST2, a member of the IL1 receptor family, is reported in this work. The method utilizes a sandwich immunoassay and disposable screen-printed carbon electrodes (SPCEs). Magnetic immunoconjugates built on the surface of carboxylic acid-microsized magnetic particles (HOOC-MBs) were used to selectively capture ST2. A biotinylated secondary antibody further conjugated with a streptavidin peroxidase conjugate (Strep-HRP) was used to accomplish the sandwiching of the target protein. The immune platform exhibits great selectivity and a low limit of detection (39.6 pg mL(−1)) for ST2, allowing the determination of soluble ST2 (sST2) in plasma samples from healthy individuals and patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) in only 45 min once the immunoconjugates have been prepared. The good correlation of the obtained results with those provided by an ELISA kit performed using the same immunoreagents demonstrates the potential of the developed strategy for early diagnosis and/or prognosis of the fatal PDAC disease.
format Online
Article
Text
id pubmed-8234531
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82345312021-06-27 Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases Torrente-Rodríguez, Rebeca M. Martín, Cristina Muñoz-San Gamella, Maria Pedrero, María Martínez-Bosch, Neus Navarro, Pilar García de Frutos, Pablo Pingarrón, José M. Campuzano, Susana Biosensors (Basel) Article A magnetic beads (MB)-involved amperometric immunosensor for the determination of ST2, a member of the IL1 receptor family, is reported in this work. The method utilizes a sandwich immunoassay and disposable screen-printed carbon electrodes (SPCEs). Magnetic immunoconjugates built on the surface of carboxylic acid-microsized magnetic particles (HOOC-MBs) were used to selectively capture ST2. A biotinylated secondary antibody further conjugated with a streptavidin peroxidase conjugate (Strep-HRP) was used to accomplish the sandwiching of the target protein. The immune platform exhibits great selectivity and a low limit of detection (39.6 pg mL(−1)) for ST2, allowing the determination of soluble ST2 (sST2) in plasma samples from healthy individuals and patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) in only 45 min once the immunoconjugates have been prepared. The good correlation of the obtained results with those provided by an ELISA kit performed using the same immunoreagents demonstrates the potential of the developed strategy for early diagnosis and/or prognosis of the fatal PDAC disease. MDPI 2021-06-21 /pmc/articles/PMC8234531/ /pubmed/34205541 http://dx.doi.org/10.3390/bios11060202 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Torrente-Rodríguez, Rebeca M.
Martín, Cristina Muñoz-San
Gamella, Maria
Pedrero, María
Martínez-Bosch, Neus
Navarro, Pilar
García de Frutos, Pablo
Pingarrón, José M.
Campuzano, Susana
Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases
title Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases
title_full Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases
title_fullStr Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases
title_full_unstemmed Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases
title_short Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases
title_sort electrochemical immunosensing of st2: a checkpoint target in cancer diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234531/
https://www.ncbi.nlm.nih.gov/pubmed/34205541
http://dx.doi.org/10.3390/bios11060202
work_keys_str_mv AT torrenterodriguezrebecam electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT martincristinamunozsan electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT gamellamaria electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT pedreromaria electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT martinezboschneus electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT navarropilar electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT garciadefrutospablo electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT pingarronjosem electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases
AT campuzanosusana electrochemicalimmunosensingofst2acheckpointtargetincancerdiseases